VEGFA and breast carcinoma: We explored the role of ACE2 in breast cancer angiogenesis and found that ACE2 could inhibit breast cancer angiogenesis and metastasis both in vitro and in vivo and suppress the VEGFa/VEGFR2/ERK pathway.